Cyprotex - News
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.

Cyprotex launches new responsive website

Cyprotex today launches its new responsive website, The redesign fulfils several roles. Firstly, improved navigation; secondly, a platform where new technologies or acquisitions can be introduced more easily with maximum visibility; thirdly, a responsive website which optimises the viewing experience on different devices. The new website addresses all of these points and greatly enhances the user experience.

Commenting on the launch of the website, Dr Anthony D Baxter, Cyprotex's Chief Executive Officer, said:

“Our website is a key source of information for our customers and investors. As our portfolio of services grows, both organically and through acquisitions, it has been necessary to enhance our website to improve navigation. Mobile device usage is growing and having a responsive website which can optimise the viewing experience based on different devices is critical to keep us up-to-date with these trends. In addition to the improved functionality, sections have been introduced which are related to new testing capabilities in the personal care and chemical industries following our acquisition of CeeTox earlier this year."

Contact us

News categories


Contact us to discuss your ADME Tox issues or request a quote

North America (East Coast): 888-297-7683
Europe: +44 1625 505100


or fill out the form below:

Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.